Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of GnRH injection for intrauterine insemination in infertile women
IRCT20120215009014N287Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of gonadorelin and progesterone in female infertility (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Success of intrauterine insemination. Started Jul 2019; status: completed.
02
Drugs
gonadorelinprogesterone
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20120215009014N287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N287.